Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo”

1,195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,195 results

Testing effectiveness (Phase 2)UnknownNCT00354276
What this trial is testing

VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Vion Pharmaceuticals 85
Testing effectiveness (Phase 2)UnknownNCT03220113
What this trial is testing

Treatment of Chronic Migraine Headaches.

Who this might be right for
Chronic Migraine Without Aura, IntractableMigraine With Typical AuraMigraine Disorders
Corona Doctors Medical Clinics, Inc. 100
Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing

Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma
Large-scale testing (Phase 3)Study completedNCT00238446
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients

Who this might be right for
Patients Successfully Completing the 12-month Treatment Period of the Core Study (de Novo Heart Recipients) Who Were Interested of Being Treated With EC-MPS
Novartis Pharmaceuticals
Not applicableStudy completedNCT01470859
What this trial is testing

The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

Who this might be right for
Idiopathic Parkinson's Disease
Huashan Hospital 30
Not applicableStudy completedNCT06058741
What this trial is testing

Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy

Who this might be right for
Acute Myeloid Leukemia
AbbVie 151
Testing effectiveness (Phase 2)Study completedNCT00352001
What this trial is testing

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Mikkael Sekeres MD 37
Not applicableLooking for participantsNCT06822712
What this trial is testing

Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions

Who this might be right for
Coronary Arterial Disease (CAD)
BrosMed Medical Co., Ltd 250
Testing effectiveness (Phase 2)Ended earlyNCT06365437
What this trial is testing

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 33
Not applicableStudy completedNCT01913600
What this trial is testing

Resolute Integrity US Extended Length Sub-Study(RI US XL)

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 56
Not applicableLooking for participantsNCT05259553
What this trial is testing

Biomarkers in Multiple Myeloma

Who this might be right for
Hematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy
Centre Hospitalier Universitaire de Saint Etienne 70
Testing effectiveness (Phase 2)UnknownNCT05033964
What this trial is testing

The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 200
Testing effectiveness (Phase 2)Ended earlyNCT00282230
What this trial is testing

Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 150
Large-scale testing (Phase 3)Study completedNCT01612767
What this trial is testing

BIOHELIX-I Bare Metal Stent Study

Who this might be right for
Coronary Arteries Disease
Biotronik, Inc. 329
Not applicableStudy completedNCT01419171
What this trial is testing

The OMEGA Clinical Trial

Who this might be right for
AtherosclerosisCoronary Artery Disease
Boston Scientific Corporation 328
Not applicableUnknownNCT02360709
What this trial is testing

Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
CID S.p.A. 800
Testing effectiveness (Phase 2)Study completedNCT00096122
What this trial is testing

Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+20 more
National Cancer Institute (NCI) 95
Not applicableWithdrawnNCT01284257
What this trial is testing

Observational Registry Study of Renal Transplant Patients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02137239
What this trial is testing

Regimen Optimization Study

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 58
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Next Page